Company Profile

Weill Cornell Medicine - Qatar (WCM-Q)      
                                                                                             

Weill Cornell Medicine–Qatar is at the forefront of medical education, clinical care, and biomedical research in the Middle East. Established in 2001 as a partnership between Cornell University in the US and QF, WCM-Q is part of Cornell University and was the first US university to offer its MD degree overseas.
 

From their very first year, medical students gain clinical experience with the country’s finest healthcare providers, and go on to residencies at some of the best teaching hospitals in the world. WCM-Q’s Division of Continuing Professional Development is accredited to provide continuing medical education for physicians and in doing so disseminates information about clinical best practice, augmenting local healthcare delivery.
 

In addition, WCM-Q has a world-class biomedical research program, the first of its kind in the Middle East. WCM-Q researchers conduct investigations at the basic, translational and community levels, addressing complex diseases such as diabetes, infectious diseases such as COVID-19 and hepatitis C, and helping to inform more efficient healthcare delivery by ushering in the era of precision medicine. The biomedical research program also delivers rigorous training programs, helping to build local research capacity and contributing to Qatar’s knowledge economy.
 

Website:  https://qatar-weill.cornell.edu/